Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Docetaxel in Older Patients with Metastatic Cancer
NCT00059943Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Sep 2002
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of docetaxel in breast cancer, lung cancer and prostate cancer (PCa), sponsored by Memorial Sloan Kettering Cancer Center. Primary endpoint: Pharmacokinetics of docetaxel. Started Sep 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
breast cancerlung cancerprostate cancer (PCa)
Beyond the preview
Go deeper on NCT00059943.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00059943.